Innovation Pharmaceuticals Inc (IPIX)

[Astavakra]

p53. Interesting name choice for such an ambivalent onlooker. It does grab attention on this MB, though, so probably a good choice for your purposes.
If you haven't already, as part of your DD on CTIX, I'd suggest you listen to Dr. Alexander's presentation at the recent Biotech Showcase wherein he outlined the case of the spleen patient. You'll find it here:
http://cellceutix.com/wp-content/uploads/2014/06/CTIX-Biotech-Showcase-2015-AUDIO-1.mp3

Pay particular attention beginning around the 12 minute mark. At about 12:15 in, he opines that her disease was stable and that this is a case of 'treating the numbers and not the patient'. This is coming from a doctor with more information and familiarity with this case than any of us here. Of course, you may make of it what you will, but why not get as close to the source as possible before doing so?